ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 108

Patient Reported Outcomes Following Total Knee Arthroplasty in Rheumatoid Arthritis and Osteoarthritis

Anand Dusad1, Sofia Pedro2, Kevin Garvin3, Curtis Hartman4, James O'Dell5, Ted R. Mikuls5 and Kaleb Michaud6, 1Rheumatology, University of Nebraska Medical Center, Omaha, NE, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3Orthopaedic Surgery, University of Nebraska Medical Center, Omaha, NE, 4Orthopaedic Surgery and Rehabilitation, University of Nebraska Medical Center, Omaha, NE, 5University of Nebraska Medical Center, Omaha, NE, 6University of Nebraska Medical Center and National Data Bank, Omaha, NE

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Osteoarthritis, patient outcomes, quality of life and rheumatoid arthritis (RA), Total Knee Arthroplasty (TKA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Health Services Research

Session Type: Abstract Submissions (ACR)

Background/Purpose: Due to the progressive and debilitating nature of knee arthritis, total knee arthroplasty (TKA) is the ultimate outcome. TKA is an effective surgical intervention for relieving pain and restoring function in patients with end-stage knee arthritis. Even though the beneficial impact of TKA is well documented, its effect on patient reported indices of pain and health related quality of life (HRQoL), especially in the RA population, are scarce. We examined the effects of TKA on pain and HRQoL in RA and OA patients.

Methods: Rheumatologist-diagnosed RA (n=834) and OA (n=315) patients undergoing primary TKA during 1999-2012 were identified. Measures of pain, function and HRQoL  were obtained in three consecutive 6-month intervals: pre-operative (baseline), peri-operative and post-operative (recovery). Descriptive statistics and one-way ANOVA were used to compare TKA outcomes by diagnosis. Effect sizes were calculated between baseline and recovery period for each measure and graphs were plotted to follow these over time (±3 years of TKA), for both RA and OA patients.

Results: Patients with RA and OA were similar in age (65 vs. 68 years, respectively) and elapsed time [baseline sampling to TKA and TKA to recovery] (4.4 vs. 4.5 and 10.4 vs. 10.3 months). Post TKA, significant improvements were observed for most domains of pain, function and HRQoL indices within both disease groups (p<0.001). The beneficial effects of TKA were more profound in OA patients, as compared to RA, for all measures of pain and HRQoL indices except for RADAI/total joint count [RA (-0.42) vs. OA (-0.30)] and EQ-5D [RA (0.07) vs. OA (0.06)]. By effect size, maximum significant (p <0.001) improvement was shown in index knee pain (RA -1.69 vs. OA -1.85). Beyond pain outcomes, EQ-5D and SF-36 PCS were the most responsive HRQoL measures in detecting post-TKA improvement in RA and OA (p<0.001 in both groups), respectively (Table 1).  For all outcomes examined, improvements were greatest in the first post-operative year, showing gradual declines thereafter.

Conclusion: TKA is highly effective in reducing clinically relevant index knee pain to a greater extent than other subjective HRQoL indices in patients with RA, although this improvement is less marked than that observed in OA patients. Gains observed in pain, function, and HRQoL are most striking in the first 12 months following TKA, paralleling levels reported often years prior to joint replacement. From our results, TKA acts as a “time machine” by which a patient returns to a reduced pain and less disabled lifestyle, before the arthritic process catches up, which is strikingly faster in RA.

Table 1. Mean change (SD) and effect size between baseline and recovery period 

RA

Effect size

OA

Effect size

Index knee pain (0- 3)#

-1.47 (0.88)

-1.69

-1.47 (0.79)

-1.85

VAS Pain (0 – 10)#

-1.12 (2.67)

-0.42

-1.74 (2.60)

-0.67

RADAI-Total joint count (0 – 16)@

-0.40 (4.92)

0.08

-0.31 (4.61)

-0.07

RADAI-Total joint score (0 – 48)@

-1.41 (10.07)

-0.14

-1.88 (8.47)

-0.22

HAQ@

-0.09 (0.66)

-0.14

-0.15 (0.59)

-0.25

HAQ  II

-0.18 (0.64)

-0.29

-0.19 (0.58)

-0.32

SF-36 PCS (0 -100)

3.59 (9.80)

0.37

4.57 (9.89)

0.46

EQ-5D (US) (0-1)

0.07 (0.20)

0.40

0.06 (0.20)

0.32

# and @ represent indices with significantly (p<0.05) less and more severe scores, respectively, in RA (vs. OA) patients undergoing TKA at baseline. Bold numbers represent significant (p <0.05) values between baseline and recovery within the respective groups


Disclosure:

A. Dusad,
None;

S. Pedro,
None;

K. Garvin,
None;

C. Hartman,
None;

J. O’Dell,

Abbvie, Lilly, Antares, Medac,

5;

T. R. Mikuls,
None;

K. Michaud,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/patient-reported-outcomes-following-total-knee-arthroplasty-in-rheumatoid-arthritis-and-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences